William G. Rice - 25 Nov 2024 Form 4 Insider Report for Aptose Biosciences Inc. (APTOF)

Role
Chair, President & CEO, Director
Signature
/s/ William G. Rice
Issuer symbol
APTOF
Transactions as of
25 Nov 2024
Net transactions value
+$20,000
Form type
4
Filing time
26 Nov 2024, 18:56:32 UTC
Previous filing
07 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APTO Common Shares Purchase $20,000 +100,000 +19% $0.2000 613,252 25 Nov 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APTO Warrants Purchase +50,000 50,000 25 Nov 2024 Common Shares 50,000 $0.2500 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares and warrants were acquired as part of an Issuer unit offering, each unit priced at $0.20 consisting of one common share and one-half of one common share purchase warrant.